A comprehensive overview of AL amyloidosis disease characteristics accumulated over two decades at a single referral center in Korea
Sang Eun Yoon(Sungkyunkwan University), Kihyun Kım(State University of New York), Eun‐Seok Jeon, Jin‐Oh Choi, Darae Kim(British Heart Foundation), Jung Eun Lee(Samsung Medical Center), Jung‐Sun Kim(Samsung Medical Center), Joon Young Choi(Samsung Medical Center), Byoung Joon Kim(Samsung Medical Center), Ju‐Hong Min(Samsung (South Korea)), Seok Jin Kim(Samsung (South Korea))
Cited by 4
Related Papers
Development of a nanostructured DNA delivery scaffold via electrospinning of PLGA and PLA–PEG block copolymers
|Journal of Controlled Release|2003|793
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
|New England Journal of Medicine|2023|719
Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy
|New England Journal of Medicine|2024|356
Development of extensive brain lesions following fingolimod (FTY720) treatment in a patient with neuromyelitis optica spectrum disorder
|Multiple Sclerosis Journal|2011|284
Belantamab Mafodotin, Bortezomib, and Dexamethasone for Multiple Myeloma
|New England Journal of Medicine|2024|162